PlainRecalls
FDA Drug Low Class III Terminated

NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816

Reported: January 6, 2021 Initiated: December 22, 2020 #D-0180-2021

Product Description

NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816

Reason for Recall

Failed Moisture Limits

Details

Recalling Firm
Strides Pharma Inc.
Units Affected
960 bottles
Distribution
PA
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816. Recalled by Strides Pharma Inc.. Units affected: 960 bottles.
Why was this product recalled?
Failed Moisture Limits
Which agency issued this recall?
This recall was issued by the FDA Drug on January 6, 2021. Severity: Low. Recall number: D-0180-2021.